2025 ISAKOS Biennial Congress ePoster
    
	Outcomes Following Autologous Osteochondral Transplantation For Osteochondral Lesions Of The Talus At A Minimum Of 10-Year Follow-Up: A Retrospective Review
	
		
				
					James J. Butler, MB, BCh, New York, New York UNITED STATES
				
			
				
					Guillaume  Robert, Lille FRANCE
				
			
				
					Jari  Dahmen, MD, BSc, Amsterdam NETHERLANDS
				
			
				
					Charles C. Lin, BSE, New York, New York UNITED STATES
				
			
				
					Sebastian  Krebsbach, BS, New York UNITED STATES
				
			
				
					Joseph  Robin, MD, New York, NY UNITED STATES
				
			
				
					Alan P. Samsonov, BS, New York, NY UNITED STATES
				
			
				
					John G. Kennedy, MD, MCh, MMSc, FFSEM, FRCS (Orth), New York UNITED STATES
				
			
		
		NYU Langone Health, New York, NY, UNITED STATES
		
		FDA Status Not Applicable
	
    
		Summary
        
            Autologous osteochondral transplantation for osteochondral lesions of the talus demonstrates a 94.9% survival rate and significant improvement in clinical outcomes over a minimum of 10 years, though larger lesion sizes are associated with worse outcomes.
        
     
    
	    
		    ePosters will be available shortly before Congress
		    
	    
     
    
	    Abstract
		
        Introduction
The purpose of this study was to evaluate outcomes following autologous osteochondral transplantation (AOT) for the treatment of osteochondral lesions of the talus (OLT) at a minimum of 10-year follow-up.
Methods
Retrospective chart review identified patients who underwent AOT for the treatment of OLT. Pre-operative magnetic resonance imaging (MRI) scans were obtained in all patients. Clinical outcomes assessed included: pre- and post-operative foot and ankle outcome score (FAOS), visual analog scale (VAS), patient satisfaction, complications, failures and secondary surgical procedures.
Results
Thirty-nine patients with a mean lesion size was 122.3±64.1 mm2 and mean follow-up time of 138.9±16.9months were included. The mean FAOS scores improved from a preoperative score of 51.9±16.0 to 75.3±21.9 (p< 0.001). Increasing lesion size was variable associated with inferior FAOS scores (R2=0.2228). There was statistically significant higher mean T2 relaxation values at the superficial layer at the site of the AOT graft (42.9±5.2ms) compared to the superficial layer of the adjacent native cartilage (35.8±3.8ms) (p< 0.001). Seventeen complications (43.6%) were observed, the most common of which was anterior ankle impingement (25.6%). There were 2 failures (5.1%), both of which had a history of prior bone marrow stimulation via microfracture and post-operative cysts identified on MRI.
Discussion And Conclusion
This retrospective review found that AOT for the treatment of large OLTs produced a 94.9% survival rate at a minimum of 10-year follow-up. Increasing lesion size was associated with inferior clinical outcomes. The findings of this study indicates that AOT is a viable long-term surgical strategy for the treatment of large OLTs.